From the available clinical reports, most of the abnormal cardiac troponin levels following onasemnogene abeparvovec treatment are accompanied by transaminases, particularly alanine aminotransferase (ALT) and aspartate aminotransferase (AST), in the setting of liver injury or hepatitis. The gene discussed is GPT; the disease is Hepatitis.